Non-exudative “Dry” Age-Related Macular Degeneration (AMD) Studies

Status: Terminated

ClinicalTrials.gov Identifier: NCT01577381

Pfizer B1181003: Multiple doses of RN6G by infusion in patients with Geograpic Atrophy secondary to Age-Related Macular Degeneration.

Condition: Age-Related Maculopathy

Study Type: Interventional

Duration: 14 months

Eligibility:

  • Ages: 60 years to 90 years
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here


Status: Completed

ClinicalTrials.gov Identifier: NCT01010997

Foresee Home Device: Intended for the early detection of AMD.

Condition: Age-Related Macular Degeneration

Study Type: Observational

Duration: 3 years

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.